WCM-Rutgers NJMS CTU Supplement for COVID Testing

WCM-Rutgers NJMS CTU 针对新冠病毒检测的补充

• 批准号: 10166397
• 负责人: ROY M. GULICK
• 金额: $ 30万
• 依托单位: WEILL MEDICAL COLL OF CORNELL UNIV
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-06-16 至 2021-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10166397
• 关键词: AIDS clinical trial group; Acquired Immunodeficiency Syndrome; Address; Administrative Supplement; Adult Respiratory Distress Syndrome; Affect; Area; COVID-19; COVID-19 pandemic; Clinical; Clinical Trials; Clinical Trials Network; Clinical Trials Unit; Communities; Community Healthcare; Coronavirus; Enrollment; Ensure; Funding; Future; HIV prevention trials network; Health Personnel; Individual; Infection; Laboratories; Lesbian Gay Bisexual Transgender Queer; Location; Minority; New Jersey; Research Institute; Services; Severe Acute Respiratory Syndrome; Site; Testing; United States; Work; clinical research site; cohort; coronavirus disease; high risk population; infection rate; interest; medical schools; named group; pandemic disease; programs; public health research

ABSTRACT The Rutgers New Jersey Medical School (NJMS) Clinical Research Site (CRS) 31786 is requesting $300,000 in funding to help support Severe Acute Respiratory Distress Syndrome Coronavirus-2 (SARS-CoV-2) testing. The CRS is part of the Weill Cornell-Rutgers NJMS Clinical Trials Unit and has been a site for two Division of AIDS (DAIDS) funded clinical trials networks: AIDS Clinical Trials Group (ACTG) and HIV Prevention Trials Network (HPTN) for fifteen years. The program plans to provide SARS-CoV-2 testing by leveraging its existing relationships with the local community and partnering with the clinical laboratory located at Public Health Research Institute (PHRI), also a Rutgers facility to perform SARS-CoV-2 testing using the Cepheid testing platform. The Cepheid COVID-19 testing platform has been developed at PHRI with Cepheid and is one of the most sensitive tests currently available to detect SARS-Co-V 2 infection. We will provide SARS-CoV-2 testing at the CRS, in an adjacent building and on a mobile van. These testing locations are well-known and easily accessible to the community, healthcare workers and other high-risk groups. We will also attempt to ensure that special populations such as minorities and the LGBTQ community have access to the test. Finally, this will help the CRS further strengthen its relationship with the community and allow the unit to provide an essential service to this hard-hit community. If funded, this project will allow us to rapidly increase the availability of SARS CoV-2 testing and help contribute to the urgent need for additional COVID testing in an underserved community located near the epicenter of the COVID-19 pandemic in the United States.

摘要 新泽西罗格斯医学院临床研究网站(CRS)31786是 申请拨款30万元支援严重急性呼吸系统窘迫综合症 冠状病毒2型(SARS-CoV-2)检测。CRS是威尔康奈尔-罗格斯NJMS的一部分 临床试验单位，一直是艾滋病(DAIDS)资助的两个部门的临床试验的地点 网络：艾滋病临床试验小组(ACTG)和艾滋病毒预防试验网络(HPTN) 十五年了。 该计划计划利用其现有的关系提供SARS-CoV-2检测 当地社区并与位于公共卫生部门的临床实验室合作 研究所(PHRI)，也是罗格斯大学的一家机构，使用 造父变星测试平台。造父变身新冠肺炎测试平台已在北京物理研究院开发 是目前检测SARS-Co-V2最敏感的检测方法之一 感染。 我们会在社区康复中心、毗邻的建筑物和一辆流动货车上进行SARS-CoV-2测试。 这些测试地点是众所周知的，并且很容易被社区、医疗保健部门访问 工人和其他高危群体。我们还将努力确保像这样的特殊人口 因为少数民族和LGBTQ社区可以获得测试。最后，这将有助于CRS 进一步加强其与社区的关系，并使该股能够提供必要的 为这个遭受重创的社区服务。 如果获得资金，这个项目将使我们能够迅速增加SARS CoV-2检测和 在服务不足的社区帮助满足对额外COVID检测的迫切需求 位于美国新冠肺炎疫情的震中附近。